Variant report
Variant | esv2582194 |
---|---|
Chromosome Location | chr13:38022734-38024240 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563057249 | chr13:38022734-38022735 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189080359 | chr13:38022767-38022768 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548792540 | chr13:38022787-38022788 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546688073 | chr13:38022788-38022789 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs576470208 | chr13:38022789-38022790 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559218528 | chr13:38022791-38022792 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528410190 | chr13:38022795-38022796 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551390234 | chr13:38022804-38022805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571590013 | chr13:38022809-38022810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537066757 | chr13:38022810-38022811 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs75881841 | chr13:38022889-38022890 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200430941 | chr13:38022890-38022891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146852906 | chr13:38022901-38022902 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551040145 | chr13:38022922-38022923 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs148192296 | chr13:38022957-38022958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2323492 | chr13:38022966-38022967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567790487 | chr13:38022984-38022985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568020867 | chr13:38023005-38023006 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs17055650 | chr13:38023012-38023013 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs553646031 | chr13:38023028-38023029 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573488747 | chr13:38023054-38023055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs142085937 | chr13:38023090-38023091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192346650 | chr13:38023091-38023092 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577529338 | chr13:38023092-38023093 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543084049 | chr13:38023111-38023112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9576271 | chr13:38023157-38023158 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs573447859 | chr13:38023166-38023167 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs61947267 | chr13:38023186-38023187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs57846748 | chr13:38023219-38023220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs56001644 | chr13:38023225-38023226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs55749189 | chr13:38023227-38023228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113523059 | chr13:38023266-38023267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs9635083 | chr13:38023299-38023300 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559272310 | chr13:38023362-38023363 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528297340 | chr13:38023364-38023365 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577536720 | chr13:38023425-38023426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565068050 | chr13:38023429-38023430 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs184485940 | chr13:38023450-38023451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187361995 | chr13:38023452-38023453 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs115480938 | chr13:38023462-38023463 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530179033 | chr13:38023477-38023478 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191791815 | chr13:38023530-38023531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562993555 | chr13:38023538-38023539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs367872768 | chr13:38023560-38023561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs567040168 | chr13:38023564-38023565 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs73176517 | chr13:38023590-38023591 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs559186689 | chr13:38023599-38023600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs73464424 | chr13:38023611-38023612 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs537045849 | chr13:38023635-38023636 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs58722541 | chr13:38023642-38023643 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Prostate cancer | 21965145 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Monoclonal gammopathy of undetermined significance | 19135901 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:38020200-38022800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr13:38020200-38022800 | Enhancers | HSMMtube | muscle |
3 | chr13:38020400-38022800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr13:38020400-38024200 | Enhancers | Fetal Stomach | stomach |
5 | chr13:38021400-38022800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr13:38021400-38022800 | Enhancers | Stomach Smooth Muscle | stomach |
7 | chr13:38021400-38025000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr13:38021400-38027200 | Weak transcription | Osteobl | bone |
9 | chr13:38021600-38023200 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr13:38021800-38022800 | Enhancers | Colon Smooth Muscle | Colon |
11 | chr13:38022000-38022800 | Enhancers | Rectal Smooth Muscle | rectum |
12 | chr13:38022400-38022800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr13:38022400-38026200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr13:38022600-38026200 | Weak transcription | NHDF-Ad | bronchial |
15 | chr13:38022800-38023800 | Weak transcription | Rectal Smooth Muscle | rectum |
16 | chr13:38022800-38025400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
17 | chr13:38022800-38026000 | Weak transcription | Colon Smooth Muscle | Colon |
18 | chr13:38022800-38027000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr13:38022800-38027400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr13:38023200-38023600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
21 | chr13:38023600-38024400 | Enhancers | Muscle Satellite Cultured Cells | -- |
22 | chr13:38023800-38024000 | Enhancers | Rectal Smooth Muscle | rectum |
23 | chr13:38024200-38026400 | Weak transcription | Fetal Stomach | stomach |